nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP2A6—Fluorouracil—colon cancer	0.406	0.564	CbGbCtD
Methoxsalen—CYP1A2—Fluorouracil—colon cancer	0.155	0.215	CbGbCtD
Methoxsalen—CYP3A4—Irinotecan—colon cancer	0.0846	0.118	CbGbCtD
Methoxsalen—CYP3A4—Vincristine—colon cancer	0.0739	0.103	CbGbCtD
Methoxsalen—Device related infection—Fluorouracil—colon cancer	0.03	0.107	CcSEcCtD
Methoxsalen—Sunburn—Methotrexate—colon cancer	0.00897	0.032	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Fluorouracil—colon cancer	0.00876	0.0312	CcSEcCtD
Methoxsalen—Blister—Fluorouracil—colon cancer	0.00723	0.0257	CcSEcCtD
Methoxsalen—Leukoderma—Methotrexate—colon cancer	0.00637	0.0227	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Capecitabine—colon cancer	0.00612	0.0218	CcSEcCtD
Methoxsalen—Tenderness—Fluorouracil—colon cancer	0.00597	0.0213	CcSEcCtD
Methoxsalen—Herpes simplex—Fluorouracil—colon cancer	0.00565	0.0201	CcSEcCtD
Methoxsalen—Inflammation—Fluorouracil—colon cancer	0.00537	0.0191	CcSEcCtD
Methoxsalen—Blister—Capecitabine—colon cancer	0.00505	0.018	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Methotrexate—colon cancer	0.00455	0.0162	CcSEcCtD
Methoxsalen—Folliculitis—Methotrexate—colon cancer	0.00431	0.0154	CcSEcCtD
Methoxsalen—Dermatitis bullous—Fluorouracil—colon cancer	0.00396	0.0141	CcSEcCtD
Methoxsalen—Herpes simplex—Capecitabine—colon cancer	0.00395	0.0141	CcSEcCtD
Methoxsalen—Inflammation—Capecitabine—colon cancer	0.00375	0.0134	CcSEcCtD
Methoxsalen—Skin exfoliation—Capecitabine—colon cancer	0.00347	0.0124	CcSEcCtD
Methoxsalen—Dry skin—Fluorouracil—colon cancer	0.00347	0.0123	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Vincristine—colon cancer	0.0032	0.0114	CcSEcCtD
Methoxsalen—Depression—Vincristine—colon cancer	0.00311	0.0111	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Fluorouracil—colon cancer	0.00298	0.0106	CcSEcCtD
Methoxsalen—Herpes simplex—Methotrexate—colon cancer	0.00294	0.0105	CcSEcCtD
Methoxsalen—Inflammation—Methotrexate—colon cancer	0.00279	0.00995	CcSEcCtD
Methoxsalen—Dermatitis bullous—Capecitabine—colon cancer	0.00276	0.00985	CcSEcCtD
Methoxsalen—Skin exfoliation—Methotrexate—colon cancer	0.00259	0.00922	CcSEcCtD
Methoxsalen—Arrhythmia—Irinotecan—colon cancer	0.00244	0.00869	CcSEcCtD
Methoxsalen—Dry skin—Capecitabine—colon cancer	0.00242	0.00863	CcSEcCtD
Methoxsalen—Arrhythmia—Fluorouracil—colon cancer	0.00234	0.00832	CcSEcCtD
Methoxsalen—Muscle spasms—Irinotecan—colon cancer	0.00229	0.00814	CcSEcCtD
Methoxsalen—Erythema—Fluorouracil—colon cancer	0.00228	0.00811	CcSEcCtD
Methoxsalen—Ill-defined disorder—Irinotecan—colon cancer	0.00221	0.00786	CcSEcCtD
Methoxsalen—Vertigo—Vincristine—colon cancer	0.00219	0.00781	CcSEcCtD
Methoxsalen—Malaise—Irinotecan—colon cancer	0.00214	0.00764	CcSEcCtD
Methoxsalen—Vertigo—Irinotecan—colon cancer	0.00214	0.00761	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Capecitabine—colon cancer	0.00208	0.00743	CcSEcCtD
Methoxsalen—Depression—Capecitabine—colon cancer	0.00203	0.00723	CcSEcCtD
Methoxsalen—Discomfort—Irinotecan—colon cancer	0.002	0.00712	CcSEcCtD
Methoxsalen—Oedema—Vincristine—colon cancer	0.00199	0.0071	CcSEcCtD
Methoxsalen—Infection—Vincristine—colon cancer	0.00198	0.00705	CcSEcCtD
Methoxsalen—Oedema—Irinotecan—colon cancer	0.00194	0.00691	CcSEcCtD
Methoxsalen—Infection—Irinotecan—colon cancer	0.00193	0.00687	CcSEcCtD
Methoxsalen—Discomfort—Fluorouracil—colon cancer	0.00192	0.00682	CcSEcCtD
Methoxsalen—Hypotension—Vincristine—colon cancer	0.00186	0.00663	CcSEcCtD
Methoxsalen—Oedema—Fluorouracil—colon cancer	0.00186	0.00662	CcSEcCtD
Methoxsalen—Infection—Fluorouracil—colon cancer	0.00185	0.00658	CcSEcCtD
Methoxsalen—Hypotension—Irinotecan—colon cancer	0.00181	0.00646	CcSEcCtD
Methoxsalen—Insomnia—Vincristine—colon cancer	0.0018	0.00642	CcSEcCtD
Methoxsalen—Insomnia—Irinotecan—colon cancer	0.00175	0.00625	CcSEcCtD
Methoxsalen—Hypotension—Fluorouracil—colon cancer	0.00174	0.00619	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Vincristine—colon cancer	0.00172	0.00613	CcSEcCtD
Methoxsalen—Dyspepsia—Irinotecan—colon cancer	0.00171	0.00608	CcSEcCtD
Methoxsalen—Insomnia—Fluorouracil—colon cancer	0.00168	0.00599	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Irinotecan—colon cancer	0.00167	0.00597	CcSEcCtD
Methoxsalen—Dyspepsia—Fluorouracil—colon cancer	0.00164	0.00583	CcSEcCtD
Methoxsalen—Arrhythmia—Capecitabine—colon cancer	0.00163	0.00582	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Fluorouracil—colon cancer	0.0016	0.00572	CcSEcCtD
Methoxsalen—Feeling abnormal—Irinotecan—colon cancer	0.0016	0.0057	CcSEcCtD
Methoxsalen—Erythema—Capecitabine—colon cancer	0.00159	0.00567	CcSEcCtD
Methoxsalen—Body temperature increased—Vincristine—colon cancer	0.00157	0.00561	CcSEcCtD
Methoxsalen—Dysgeusia—Capecitabine—colon cancer	0.00156	0.00555	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Methotrexate—colon cancer	0.00155	0.00553	CcSEcCtD
Methoxsalen—Body temperature increased—Irinotecan—colon cancer	0.00153	0.00546	CcSEcCtD
Methoxsalen—Feeling abnormal—Fluorouracil—colon cancer	0.00153	0.00546	CcSEcCtD
Methoxsalen—Muscle spasms—Capecitabine—colon cancer	0.00153	0.00545	CcSEcCtD
Methoxsalen—Depression—Methotrexate—colon cancer	0.00151	0.00538	CcSEcCtD
Methoxsalen—Ill-defined disorder—Capecitabine—colon cancer	0.00148	0.00526	CcSEcCtD
Methoxsalen—Urticaria—Fluorouracil—colon cancer	0.00148	0.00526	CcSEcCtD
Methoxsalen—Body temperature increased—Fluorouracil—colon cancer	0.00147	0.00523	CcSEcCtD
Methoxsalen—Hypersensitivity—Vincristine—colon cancer	0.00147	0.00523	CcSEcCtD
Methoxsalen—Malaise—Capecitabine—colon cancer	0.00143	0.00511	CcSEcCtD
Methoxsalen—Vertigo—Capecitabine—colon cancer	0.00143	0.00509	CcSEcCtD
Methoxsalen—Hypersensitivity—Irinotecan—colon cancer	0.00143	0.00509	CcSEcCtD
Methoxsalen—Hypersensitivity—Fluorouracil—colon cancer	0.00137	0.00488	CcSEcCtD
Methoxsalen—Discomfort—Capecitabine—colon cancer	0.00134	0.00477	CcSEcCtD
Methoxsalen—Dizziness—Vincristine—colon cancer	0.00132	0.00469	CcSEcCtD
Methoxsalen—Pruritus—Fluorouracil—colon cancer	0.00131	0.00468	CcSEcCtD
Methoxsalen—Oedema—Capecitabine—colon cancer	0.0013	0.00463	CcSEcCtD
Methoxsalen—Infection—Capecitabine—colon cancer	0.00129	0.0046	CcSEcCtD
Methoxsalen—Dizziness—Irinotecan—colon cancer	0.00128	0.00457	CcSEcCtD
Methoxsalen—Skin disorder—Capecitabine—colon cancer	0.00126	0.00449	CcSEcCtD
Methoxsalen—Rash—Vincristine—colon cancer	0.00126	0.00448	CcSEcCtD
Methoxsalen—Dermatitis—Vincristine—colon cancer	0.00125	0.00447	CcSEcCtD
Methoxsalen—Headache—Vincristine—colon cancer	0.00125	0.00445	CcSEcCtD
Methoxsalen—Dizziness—Fluorouracil—colon cancer	0.00123	0.00438	CcSEcCtD
Methoxsalen—Rash—Irinotecan—colon cancer	0.00122	0.00436	CcSEcCtD
Methoxsalen—Dermatitis—Irinotecan—colon cancer	0.00122	0.00435	CcSEcCtD
Methoxsalen—Headache—Irinotecan—colon cancer	0.00122	0.00433	CcSEcCtD
Methoxsalen—Hypotension—Capecitabine—colon cancer	0.00121	0.00432	CcSEcCtD
Methoxsalen—Erythema—Methotrexate—colon cancer	0.00118	0.00422	CcSEcCtD
Methoxsalen—Nausea—Vincristine—colon cancer	0.00118	0.00422	CcSEcCtD
Methoxsalen—Insomnia—Capecitabine—colon cancer	0.00117	0.00418	CcSEcCtD
Methoxsalen—Rash—Fluorouracil—colon cancer	0.00117	0.00417	CcSEcCtD
Methoxsalen—Dermatitis—Fluorouracil—colon cancer	0.00117	0.00417	CcSEcCtD
Methoxsalen—Headache—Fluorouracil—colon cancer	0.00116	0.00415	CcSEcCtD
Methoxsalen—Dysgeusia—Methotrexate—colon cancer	0.00116	0.00413	CcSEcCtD
Methoxsalen—Nausea—Irinotecan—colon cancer	0.00115	0.00411	CcSEcCtD
Methoxsalen—Dyspepsia—Capecitabine—colon cancer	0.00114	0.00407	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Capecitabine—colon cancer	0.00112	0.00399	CcSEcCtD
Methoxsalen—Nausea—Fluorouracil—colon cancer	0.0011	0.00393	CcSEcCtD
Methoxsalen—Ill-defined disorder—Methotrexate—colon cancer	0.0011	0.00392	CcSEcCtD
Methoxsalen—Feeling abnormal—Capecitabine—colon cancer	0.00107	0.00381	CcSEcCtD
Methoxsalen—Malaise—Methotrexate—colon cancer	0.00107	0.00381	CcSEcCtD
Methoxsalen—Vertigo—Methotrexate—colon cancer	0.00106	0.00379	CcSEcCtD
Methoxsalen—Urticaria—Capecitabine—colon cancer	0.00103	0.00368	CcSEcCtD
Methoxsalen—Body temperature increased—Capecitabine—colon cancer	0.00103	0.00366	CcSEcCtD
Methoxsalen—Discomfort—Methotrexate—colon cancer	0.000996	0.00355	CcSEcCtD
Methoxsalen—Infection—Methotrexate—colon cancer	0.00096	0.00342	CcSEcCtD
Methoxsalen—Hypersensitivity—Capecitabine—colon cancer	0.000957	0.00341	CcSEcCtD
Methoxsalen—Skin disorder—Methotrexate—colon cancer	0.000939	0.00335	CcSEcCtD
Methoxsalen—Pruritus—Capecitabine—colon cancer	0.000919	0.00327	CcSEcCtD
Methoxsalen—Hypotension—Methotrexate—colon cancer	0.000903	0.00322	CcSEcCtD
Methoxsalen—Insomnia—Methotrexate—colon cancer	0.000874	0.00312	CcSEcCtD
Methoxsalen—Dizziness—Capecitabine—colon cancer	0.000859	0.00306	CcSEcCtD
Methoxsalen—Dyspepsia—Methotrexate—colon cancer	0.000851	0.00303	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Methotrexate—colon cancer	0.000835	0.00297	CcSEcCtD
Methoxsalen—Rash—Capecitabine—colon cancer	0.000819	0.00292	CcSEcCtD
Methoxsalen—Dermatitis—Capecitabine—colon cancer	0.000818	0.00291	CcSEcCtD
Methoxsalen—Headache—Capecitabine—colon cancer	0.000813	0.0029	CcSEcCtD
Methoxsalen—Feeling abnormal—Methotrexate—colon cancer	0.000797	0.00284	CcSEcCtD
Methoxsalen—Nausea—Capecitabine—colon cancer	0.000771	0.00275	CcSEcCtD
Methoxsalen—Urticaria—Methotrexate—colon cancer	0.000768	0.00274	CcSEcCtD
Methoxsalen—Body temperature increased—Methotrexate—colon cancer	0.000764	0.00272	CcSEcCtD
Methoxsalen—Hypersensitivity—Methotrexate—colon cancer	0.000712	0.00254	CcSEcCtD
Methoxsalen—Pruritus—Methotrexate—colon cancer	0.000684	0.00244	CcSEcCtD
Methoxsalen—Dizziness—Methotrexate—colon cancer	0.000639	0.00228	CcSEcCtD
Methoxsalen—Rash—Methotrexate—colon cancer	0.000609	0.00217	CcSEcCtD
Methoxsalen—Dermatitis—Methotrexate—colon cancer	0.000609	0.00217	CcSEcCtD
Methoxsalen—Headache—Methotrexate—colon cancer	0.000606	0.00216	CcSEcCtD
Methoxsalen—Nausea—Methotrexate—colon cancer	0.000574	0.00205	CcSEcCtD
